ADALIMUMAB Side Effects

6936263-8 | Glomerulonephritis, Renal Failure
on Aug 13, 2010 Male patient from TAIWAN, PROVINCE OF CHINA , 28 years of age, was diagnosed with arthritis reactive and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: glomerulonephritis, renal failure. Adalimumab dosage: . Patient was hospitalized.

6925836-4 | Deep Vein Thrombosis
Patient was taking Adalimumab (View Usage). Patient had the following side effects: deep vein thrombosis (What is deep vein thrombosis?) on Aug 13, 2010 from UNITED STATES Additional patient health information: Male patient , 55 years of age, weighting 213.8 lb, was diagnosed with psoriasis and. Adalimumab dosage: Sq. Patient was hospitalized.

6924223-2 | Dermatomyositis
Adverse event was reported on Aug 05, 2010 by a Female patient taking Adalimumab (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 33 years of age, After Adalimumab was administered, patient had the following side effects: dermatomyositis. During the same period patient was treated with ETANERCEPT (View Etanercept Review and Etanercept Label ). Patient was hospitalized.

6924220-7 | Dermatomyositis
on Aug 05, 2010 Female patient from UNITED STATES , 29 years of age, was diagnosed with seronegative arthritis and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: dermatomyositis. Adalimumab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.


6924219-0 | Dermatomyositis
on Aug 05, 2010 Male patient from UNITED STATES , 51 years of age, was diagnosed with seronegative arthritis and was treated with Adalimumab (View Usage). Patient had the following side effects: dermatomyositis. Adalimumab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6900114-8 | Acute Lymphocytic Leukaemia, Leukaemia Recurrent
Patient was taking Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: acute lymphocytic leukaemia, leukaemia recurrent on Jul 26, 2010 from ITALY Additional patient health information: Female patient , 63 years of age, was diagnosed with crohn's disease (What is crohn's disease?), immunosuppression and. Adalimumab dosage: Dose 1. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), STEROIDS (3 Cycles Per Year For Many Years) (View Steroids Review and Steroids Label ).

6879623-6 | Aortic Thrombosis
Adverse event was reported on Jul 22, 2010 by a Female patient taking Adalimumab (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: FRANCE , 25 years of age, Patient experienced the following unwanted or unexpected effects: aortic thrombosis. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6879621-2 | Aortic Thrombosis
on Jul 22, 2010 Female patient from FRANCE , 24 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Adalimumab (View Usage). Patient had the following side effects: aortic thrombosis. Adalimumab dosage: . During the same period patient was treated with ESTROPROGESTATIVE CONTRACEPTION (View Estroprogestative Contraception Review and Estroprogestative Contraception Label ). Patient was hospitalized.

6860428-7 | Sydenham's Chorea
on Jul 12, 2010 Female patient from ITALY , child 10 years of age, was diagnosed with juvenile arthritis and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: sydenham's chorea. Adalimumab dosage: . During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

6832350-3 | Cervical Dysplasia
Patient was taking Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: cervical dysplasia on Jul 02, 2010 from GERMANY Additional patient health information: Female patient , 20 years of age, was diagnosed with juvenile arthritis and. Adalimumab dosage: . During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), ETANERCEPT (View Etanercept Review and Etanercept Label ), LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ), INDOMETHACIN (View Indomethacin Review and Indomethacin Label ), DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), HYDROXYCHLOROQUINE (View Hydroxychloroquine Review and Hydroxychloroquine Label ).

6785779-6 | Multiple Sclerosis, Optic Neuritis, Visual Acuity Reduced
Adverse event was reported on Jun 22, 2010 by a Female patient taking Adalimumab (View Usage) (Dosage: 40mg Q 2 Weeks Sc) was diagnosed with uveitis and. Location: UNITED STATES , 39 years of age, weighting 200.0 lb, Patient had the following side effects: multiple sclerosis (What is multiple sclerosis?), optic neuritis, visual acuity reduced.

6777830-4 | Coccidioidomycosis
on Jun 03, 2010 Male patient from UNITED STATES , 50 years of age, was diagnosed with crohn's disease (What is crohn's disease?), coccidioidomycosis and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: coccidioidomycosis. Adalimumab dosage: . During the same period patient was treated with MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), MESALAZINE (View Mesalazine Review and Mesalazine Label ), HYOSCYAMINE (View Hyoscyamine Review and Hyoscyamine Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ).

6730710-2 | Oesophageal Carcinoma
on May 14, 2010 Male patient from COLOMBIA , weighting 141.1 lb, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal carcinoma. Adalimumab dosage: .

6719185-7 | Idiopathic Thrombocytopenic Purpura
Patient was taking Adalimumab (View Usage). Patient had the following side effects: idiopathic thrombocytopenic purpura on May 10, 2010 from UNITED STATES Additional patient health information: Male patient , 50 years of age, weighting 153.9 lb, was diagnosed with psoriasis and. Adalimumab dosage: 40 Mg Other Sq. Patient was hospitalized.

6712107-4 | Lichen Planus, Malignant Melanoma
Adverse event was reported on Apr 27, 2010 by a Male patient taking Adalimumab (View Usage) (Dosage: Not Reported) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: FRANCE , 69 years of age, After Adalimumab was administered, patient had the following side effects: lichen planus, malignant melanoma.

6702875-X | Histiocytosis Haematophagic, Visceral Leishmaniasis
on Apr 19, 2010 Male patient from SPAIN , 60 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: histiocytosis haematophagic, visceral leishmaniasis. Adalimumab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ). Patient was hospitalized.

6697287-1 | Lichen Planus, Malignant Melanoma
on Apr 16, 2010 Male patient from FRANCE , 69 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Adalimumab (View Usage). Patient had the following side effects: lichen planus, malignant melanoma. Adalimumab dosage: Not Reported.

6692841-5 | Hepatic Failure, Hepatitis B
Patient was taking Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: hepatic failure, hepatitis b (What is hepatitis b?) on Apr 12, 2010 from JAPAN Additional patient health information: Female patient , 71 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Adalimumab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6675696-4 | Subacute Hepatic Failure
Adverse event was reported on Apr 01, 2010 by a Male patient taking Adalimumab (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: BELGIUM , 64 years of age, Patient experienced the following unwanted or unexpected effects: subacute hepatic failure. During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6673603-1 | Hepatic Failure, Hepatitis B, Sepsis
on Apr 06, 2010 Female patient from JAPAN , 71 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Adalimumab (View Usage). Patient had the following side effects: hepatic failure, hepatitis b (What is hepatitis b?), sepsis (What is sepsis?). Adalimumab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ).

6649332-7 | Takayasu's Arteritis
on Mar 18, 2010 Female patient from CANADA , 39 years of age, was diagnosed with takayasu's arteritis and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: takayasu's arteritis. Adalimumab dosage: . During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ), CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ).

6607977-4 | Pruritus, Rash, Urticaria
Patient was taking Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: pruritus, rash (What is rash?), urticaria on Feb 26, 2010 from UNITED STATES Additional patient health information: Male patient , 54 years of age, . Adalimumab dosage: 40 Mg Other Sq.

6607971-3 | Pneumonia
Adverse event was reported on Feb 26, 2010 by a Male patient taking Adalimumab (View Usage) (Dosage: 40 Mg Other Im) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: UNITED STATES , 56 years of age, weighting 256.0 lb, Patient had the following side effects: pneumonia (What is pneumonia?). Patient was hospitalized.

6585984-8 | Abdominal Pain Upper, Autoimmune Hepatitis, Hepatomegaly, Nausea
on Feb 11, 2010 Female patient from ISRAEL , 36 years of age, was diagnosed with psoriatic arthropathy and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: abdominal pain upper, autoimmune hepatitis, hepatomegaly, nausea (What is nausea?). Adalimumab dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), STEROIDS (Not Reported) (View Steroids Review and Steroids Label ). Patient was hospitalized.

6582901-1 | Cardiac Failure, Liver Disorder, Pleural Effusion
on Feb 08, 2010 Female patient from SPAIN , 64 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure, liver disorder, pleural effusion. Adalimumab dosage: . During the same period patient was treated with LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ). Patient was hospitalized.

6579508-9 | Inclusion Body Myositis
Patient was taking Adalimumab (View Usage). Patient had the following side effects: inclusion body myositis on Feb 02, 2010 from GERMANY Additional patient health information: Female patient , 57 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Adalimumab dosage: Not Reported. During the same period patient was treated with ETANERCEPT (Not Reported) (View Etanercept Review and Etanercept Label ), GLUCOCORTICOIDS (Low Dose) (View Glucocorticoids Review and Glucocorticoids Label ), METHOTREXATE (Not Reported) (View Methotrexate Review and Methotrexate Label ), LEFLUNOMIDE (Not Reported) (View Leflunomide Review and Leflunomide Label ), CYCLOSPORINE (Not Reported) (View Cyclosporine Review and Cyclosporine Label ), AZATHIOPRINE (Not Reported) (View Azathioprine Review and Azathioprine Label ), RITUXIMAB (Not Reported) (View Rituximab Review and Rituximab Label ).

6567464-9 | Cardiac Failure, Liver Disorder, Pleural Effusion
Adverse event was reported on Jan 28, 2010 by a Female patient taking Adalimumab (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Location: SPAIN , 64 years of age, After Adalimumab was administered, patient had the following side effects: cardiac failure, liver disorder, pleural effusion. During the same period patient was treated with LEFLUNOMIDE (View Leflunomide Review and Leflunomide Label ). Patient was hospitalized.

6522931-9 | Myeloproliferative Disorder
on Dec 24, 2009 Male patient from UNITED STATES , 34 years of age, was diagnosed with pouchitis and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: myeloproliferative disorder. Adalimumab dosage: . During the same period patient was treated with INFLIXIMAB (View Infliximab Review and Infliximab Label ). Patient was hospitalized.

6522929-0 |
on Dec 28, 2009 Male patient from FRANCE , 37 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Adalimumab (View Usage). . Adalimumab dosage: . During the same period patient was treated with CERTOLIZUMAB PEGOL (View Certolizumab Pegol Review and Certolizumab Pegol Label ).

6508096-8 | Graft Thrombosis, Renal Failure, Sepsis
Patient was taking Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: graft thrombosis, renal failure, sepsis (What is sepsis?) on Dec 17, 2009 from UNITED STATES Additional patient health information: Male patient , 38 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Adalimumab dosage: .

6506912-7 | Intestinal Perforation
Adverse event was reported on Dec 16, 2009 by a Female patient taking Adalimumab (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: POLAND , 23 years of age, Patient experienced the following unwanted or unexpected effects: intestinal perforation. Patient was hospitalized.

6493006-2 | Glomerulonephritis Membranous
on Dec 04, 2009 Female patient from ITALY , 61 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Adalimumab (View Usage). Patient had the following side effects: glomerulonephritis membranous. Adalimumab dosage: . During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6484740-9 | Deafness, Immune Reconstitution Syndrome, Pulmonary Tuberculosis
on Dec 02, 2009 Male patient from UNITED STATES , 38 years of age, was diagnosed with psoriasis and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: deafness, immune reconstitution syndrome, pulmonary tuberculosis. Adalimumab dosage: . Patient was hospitalized.

6482920-X | Intestinal Perforation
Patient was taking Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: intestinal perforation on Dec 02, 2009 from POLAND Additional patient health information: Female patient , 23 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and. Adalimumab dosage: . Patient was hospitalized.

6452054-9 | Cardiomyopathy
Adverse event was reported on Nov 12, 2009 by a Female patient taking Adalimumab (View Usage) (Dosage: ) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: SWITZERLAND , 25 years of age, Patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (Between 10-60 Mg) (View Prednisolone Review and Prednisolone Label ).

6449544-1 | Cardiomyopathy
on Nov 12, 2009 Male patient from SWITZERLAND , 25 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: cardiomyopathy (What is cardiomyopathy?). Adalimumab dosage: . During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), PREDNISOLONE (Between 10-60 Mg) (View Prednisolone Review and Prednisolone Label ).

6438892-7 | Cardiac Failure Congestive
on Nov 11, 2009 Male patient from UNITED STATES , 66 years of age, weighting 231.5 lb, was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive. Adalimumab dosage: 40 Mg Other Sq.

6434929-X | Lymphoma
Patient was taking Adalimumab (View Usage). Patient had the following side effects: lymphoma (What is lymphoma?) on Nov 09, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 220.5 lb, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Adalimumab dosage: 40 Mg Qoweek Subq.

6433282-5 | Oesophageal Disorder, Oral Disorder, Pharyngeal Disorder
Adverse event was reported on Nov 09, 2009 by a Female patient taking Adalimumab (View Usage) (Dosage: Titrated To 40 Mg Every 2 Wks) was diagnosed with crohn's disease (What is crohn's disease?) and. Location: UNITED STATES , 19 years of age, After Adalimumab was administered, patient had the following side effects: oesophageal disorder, oral disorder, pharyngeal disorder. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), INFLIXIMAB (View Infliximab Review and Infliximab Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6431220-2 | Oesophageal Disorder, Oral Disorder, Pharyngeal Disorder
on Oct 29, 2009 Female patient from UNITED STATES , 19 years of age, was diagnosed with crohn's disease (What is crohn's disease?) and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: oesophageal disorder, oral disorder, pharyngeal disorder. Adalimumab dosage: Titrated To 40 Mg Every 2 Wks. During the same period patient was treated with CORTICOSTEROIDS (View Corticosteroids Review and Corticosteroids Label ), METRONIDAZOLE (View Metronidazole Review and Metronidazole Label ), SULFASALAZINE (View Sulfasalazine Review and Sulfasalazine Label ), MERCAPTOPURINE (View Mercaptopurine Review and Mercaptopurine Label ), INFLIXIMAB (View Infliximab Review and Infliximab Label ), PREDNISONE (View Prednisone Review and Prednisone Label ).

6400367-9 | Nephritis, Sarcoidosis
on Oct 08, 2009 Male patient from GERMANY , 42 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Adalimumab (View Usage). Patient had the following side effects: nephritis, sarcoidosis. Adalimumab dosage: .

6399223-4 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis
Patient was taking Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: anti-neutrophil cytoplasmic antibody positive vasculitis on Oct 08, 2009 from FRANCE Additional patient health information: Female patient , 58 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Adalimumab dosage: .

6397269-3 | Breast Cancer
Adverse event was reported on Sep 29, 2009 by a Female patient taking Adalimumab (View Usage) (Dosage: ) was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?), medical diet and. Location: UNITED STATES , 62 years of age, Patient experienced the following unwanted or unexpected effects: breast cancer (What is breast cancer?). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CELECOXIB (View Celecoxib Review and Celecoxib Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ).

6391829-1 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis
on Sep 29, 2009 Female patient from FRANCE , 58 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Adalimumab (View Usage). Patient had the following side effects: anti-neutrophil cytoplasmic antibody positive vasculitis. Adalimumab dosage: .

6389779-X | Nephritis
on Sep 30, 2009 Male patient from GERMANY , 42 years of age, was diagnosed with ankylosing spondylitis (What is ankylosing spondylitis?) and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: nephritis. Adalimumab dosage: .

6381319-4 | Anti-neutrophil Cytoplasmic Antibody Positive Vasculitis
Patient was taking Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: anti-neutrophil cytoplasmic antibody positive vasculitis on Sep 21, 2009 from FRANCE Additional patient health information: Female patient , 58 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Adalimumab dosage: .

6358277-1 | Pemphigus
Adverse event was reported on Sep 09, 2009 by a Female patient taking Adalimumab (View Usage) (Dosage: ) . Location: AUSTRIA , 60 years of age, Patient had the following side effects: pemphigus (What is pemphigus?). During the same period patient was treated with METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

6358255-2 | Encephalomyelitis
on Sep 09, 2009 Female patient from ITALY , 59 years of age, was diagnosed with psoriatic arthropathy and was treated with Adalimumab (View Usage). After Adalimumab was administered, patient had the following side effects: encephalomyelitis. Adalimumab dosage: .

6311443-3 | Acute Lymphocytic Leukaemia
on Aug 07, 2009 Female patient from ITALY , 63 years of age, was diagnosed with crohn's disease (What is crohn's disease?), immunosuppression and was treated with Adalimumab (View Usage). Patient experienced the following unwanted or unexpected effects: acute lymphocytic leukaemia. Adalimumab dosage: Dose 1. During the same period patient was treated with AZATHIOPRINE (View Azathioprine Review and Azathioprine Label ), STEROIDS (3 Cycles Per Year For Many Years) (View Steroids Review and Steroids Label ).

6305371-7 | Lung Infection
Patient was taking Adalimumab (View Usage). Patient had the following side effects: lung infection on Aug 06, 2009 from GREECE Additional patient health information: Female patient , 61 years of age, was diagnosed with rheumatoid arthritis (What is rheumatoid arthritis?) and. Adalimumab dosage: Not Reported. During the same period patient was treated with METHOTREXATE (Not Reported) (View Methotrexate Review and Methotrexate Label ).